Advertisement
Advertisement

TECH

TECH logo

Bio-Techne Corp.

47.37
USD
Sponsored
+0.67
+1.43%
May 21, 16:00 UTC -4
Closed
exchange

After-Market

47.36

-0.01
-0.02%

Bio-Techne Corp. Profile

About

Bio-Techne Corporation is a global life sciences company. It develops, manufactures, and sells biotechnology products and clinical diagnostic controls. It provides proteins, such as cytokines, growth factors, and enzymes; antibodies, including polyclonal and monoclonal antibodies; immunoassays comprising quantikine kits; and clinical diagnostic immunoassay kits. The Company also offers flow cytometry products; natural and synthetic chemical compounds; hematology controls and calibrators; and hematology control products. Bio-Techne Corporation, formerly known as Techne Corporation, is headquartered in Minneapolis, Minnesota.

Info & Links

CEO

Kim Kelderman

Headquarters

614 MCKINLEY PLACE NE
MINNEAPOLIS, MN 55413, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.bio-techne.com

Auditor

KPMG LLP

Share holders

110

Employees

3,100

Bio-Techne Corp. Statistics

Valuation Measures

Market Capitalization2

7.42B

Enterprise Value

7.41B

Enterprise Value/EBITDA(ttm)

29.14

Price to Earnings Ratio(ttm)

31.57

Price to Sales(ttm)

7.15

Price to Book(mrq)

4.32

Price to Cash(ytd)

22.73

Profitability

Gross Margin(ttm)

65.22%

Operating Margin(ttm)

22.68%

Profit Margin(ttm)

6.93%

Return on Equity(ttm)

13.94%

Return on Invested Capital(ttm)

3.54%

Return on Assets(ttm)

10.76%

Income Statement

Revenue(ttm)

1.21B

Revenue Per Share(ttm)

7.73

Gross Profit(ttm)

786.49M

EBITDA(ttm)3

254.08M

Net Income Available to Common(ttm)

109.56M

Diluted EPS(ttm)

0.51

Share Statistics

Beta (5Y Monthly)

1.49

52-Week Change

-4.36%

S&P 500 52-Week Change

27.39%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

156.57M

Dividend Yield

0.58%

Float4

154.42M

% Held by Insiders

1.30%

% Held by Institutions

98.95%

Balance Sheet

Total Cash(mrq)

209.82M

Total Cash Per Share(mrq)

1.34

Total Debt(mrq)

200.00M

Total Debt/Equity(mrq)

12.93%

Current Ratio(mrq)

4.54%

Quick Ratio(mrq)

3.08%

Book Value Per Share(mrq)

12.90

Cash Flow

Operating Cash Flow Per Share(ytd)

0.70

Free Cash Flow(ytd)

98.71M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement